Enanta Pharmaceuticals
ENTA
#7543
Rank
ยฃ0.30 B
Marketcap
ยฃ10.58
Share price
1.13%
Change (1 day)
180.76%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ57.95 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.32 Million. In 2024 the company made an earning of -ยฃ71.91 Million, an increase over its 2023 earnings that were of -ยฃ94.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.95 Million-19.41%
2024 -ยฃ71.91 Million-23.87%
2023 -ยฃ94.45 Million4.39%
2022 -ยฃ90.48 Million-4.4%
2021 -ยฃ94.65 Million91.12%
2020 -ยฃ49.53 Million-407.13%
2019 ยฃ16.12 M-78.63%
2018 ยฃ75.46 M117.97%
2017 ยฃ34.62 M-574.65%
2016 -ยฃ7.3 Million-110.83%
2015 ยฃ67.36 M-4.5%
2014 ยฃ70.54 M-638.53%
2013 -ยฃ13.1 Million-137.98%
2012 ยฃ34.48 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.87 B-44,324.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.12 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ4.89 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.45 B-6,237.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.62 B-29,655.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.91 B-12,395.04%๐Ÿ‡บ๐Ÿ‡ธ USA